These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9218880)

  • 21. Auditory evoked potentials in the assessment of central nervous system effects of antimigraine drugs.
    Roon KI; Sándor PS; Schoonman GG; Lamers FP; Schoenen J; Ferrari MD; van Dijk JG
    Cephalalgia; 1999 Dec; 19(10):880-5. PubMed ID: 10668107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triptans to the rescue: effective therapy for migraine headaches in the workplace.
    Bartleson JD
    Mayo Clin Proc; 2000 Aug; 75(8):780-1. PubMed ID: 10943229
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of zolmitriptan (Zomig) on central serotonergic neurotransmission as assessed by active oddball auditory event-related potentials in volunteers without migraine.
    Hughes AM; Dixon R; Dane A; Kemp J; Cummings L; Yates RA
    Cephalalgia; 1999 Mar; 19(2):100-6; discussion 73. PubMed ID: 10214535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the trigemino-vascular system with 5-HT1D agonist drugs: selectively targeting additional sites of action.
    Martin GR
    Eur Neurol; 1996; 36 Suppl 2():13-8. PubMed ID: 8791027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90).
    Rolan P
    Cephalalgia; 1997 Oct; 17 Suppl 18():21-7. PubMed ID: 9399014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: an overview of efficacy.
    Schoenen J; Sawyer J
    Cephalalgia; 1997 Oct; 17 Suppl 18():28-40. PubMed ID: 9399015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the long-term safety and efficacy of 311C90 in the treatment of migraine.
    Geraud GE
    Eur Neurol; 1996; 36 Suppl 2():24-7. PubMed ID: 8791029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
    Martin GR
    Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Would any acute treatment for migraine demonstrate recurrence?
    Dahlöf C
    Cephalalgia; 1997 Jun; 17 Suppl 17():17-9; discussion 19-20. PubMed ID: 9218881
    [No Abstract]   [Full Text] [Related]  

  • 30. 311C90: patient profiles and typical case histories of migraine management.
    Dowson AJ
    Neurology; 1997 Mar; 48(3 Suppl 3):S29-33. PubMed ID: 9071268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zolmitriptan for migraine.
    Med Lett Drugs Ther; 1998 Feb; 40(1021):27-8. PubMed ID: 9505961
    [No Abstract]   [Full Text] [Related]  

  • 32. Zolmitriptan.
    Can Fam Physician; 1999 Jun; 45():1491-4, 1497-501. PubMed ID: 10386213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral migraine treatment approved.
    Nurse Pract; 1998 Jan; 23(1):94. PubMed ID: 9470199
    [No Abstract]   [Full Text] [Related]  

  • 34. [Medical treatment of migraine attacks in the child].
    Cuvellier JC; Joriot S; Auvin S; Vallée L
    Rev Infirm; 2006 Jan; (117):16-24. PubMed ID: 16502820
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mechanism of action of zolmitriptan].
    Pascual J
    Neurologia; 1998 Oct; 13 Suppl 2():9-15. PubMed ID: 9859690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. It never hurts to check. Taking the time to read a label benefited this migraine sufferer.
    Lilley LL; Guanci R
    Am J Nurs; 1998 Jun; 98(6):14. PubMed ID: 9629078
    [No Abstract]   [Full Text] [Related]  

  • 37. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
    Deleu D; Hanssens Y
    Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinal cord infarction during use of zolmitriptan: a case report.
    Vijayan N; Peacock JH
    Headache; 2000 Jan; 40(1):57-60. PubMed ID: 10759907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical efficacy of zolmitriptan in migraine].
    Leira R; Noya M
    Neurologia; 1998 Oct; 13 Suppl 2():16-24. PubMed ID: 9859691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Have the triptans fulfilled their promise?
    Zagami AS
    J Clin Neurosci; 2001 Sep; 8(5):476-7. PubMed ID: 11535025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.